New project aims to validate digital biomarkers for better treatment of Parkinson’s disease

By | May 31, 2021
Parkinson’s disease affects seven to ten million patients in Western societies – with an upward trend. Patients suffer from symptoms such as tremors, gait and speech disorders, and memory loss.